US6566368B2
(en)
*
|
1994-04-22 |
2003-05-20 |
Pentech Pharmaceuticals, Inc. |
Apomorphine-containing dosage form for ameliorating male erectile dysfunction
|
US5990168A
(en)
|
1996-04-18 |
1999-11-23 |
Alberta Cancer Board |
Methods and compositions for the treatment of ataxia telangiectasia
|
US7214686B2
(en)
|
1997-06-30 |
2007-05-08 |
Targacept, Inc. |
Pharmaceutical compositions and methods for effecting dopamine release
|
US6908631B1
(en)
|
1997-12-01 |
2005-06-21 |
Nicogen, Inc. |
Therapeutic and diagnostic methods dependent on CYP2A enzymes
|
US6432975B1
(en)
|
1998-12-11 |
2002-08-13 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
US6953855B2
(en)
|
1998-12-11 |
2005-10-11 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
JP2002532393A
(ja)
|
1998-12-16 |
2002-10-02 |
ユニヴァーシティー オブ サウス フロリダ |
エキソ−r−メカミラミン製剤および治療におけるその使用
|
FR2804430B1
(fr)
|
2000-01-28 |
2002-03-22 |
Sanofi Synthelabo |
Derives de 4-heteroaryl-1,4-diazabicyclo[3.2.2] nonane, leur preparation et leur application en therapeutique
|
GB0010955D0
(en)
|
2000-05-05 |
2000-06-28 |
Novartis Ag |
Organic compounds
|
AR036041A1
(es)
*
|
2001-06-12 |
2004-08-04 |
Upjohn Co |
Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
|
DE10156719A1
(de)
|
2001-11-19 |
2003-05-28 |
Bayer Ag |
Heteroarylcarbonsäureamide
|
GB0128996D0
(en)
|
2001-12-04 |
2002-01-23 |
Novartis Ag |
Organic compounds
|
DE10211416A1
(de)
|
2002-03-15 |
2003-09-25 |
Bayer Ag |
Essig- und Propionsäureamide
|
DE10211415A1
(de)
|
2002-03-15 |
2003-09-25 |
Bayer Ag |
Bicyclische N-Biarylamide
|
SE0201943D0
(sv)
|
2002-06-20 |
2002-06-20 |
Astrazeneca Ab |
New use
|
DE10234424A1
(de)
|
2002-07-29 |
2004-02-12 |
Bayer Ag |
Benzothiophen-, Benzofuran- und Indolharnstoffe
|
ATE384720T1
(de)
|
2002-08-14 |
2008-02-15 |
Neurosearch As |
Chinucledin - derivate und deren verwendung
|
EP2305664A1
(en)
|
2002-08-30 |
2011-04-06 |
Memory Pharmaceuticals Corporation |
Anabaseine derivatives useful in the treatment of neurodegeneratives diseases
|
GB0220581D0
(en)
|
2002-09-04 |
2002-10-09 |
Novartis Ag |
Organic Compound
|
RS53147B
(en)
|
2002-09-25 |
2014-06-30 |
Memory Pharmaceuticals Corporation |
INDAZOLES, BENZOTIAZOLES AND BENZOIZOTIAZOLES AND THEIR PREPARATION AND THEIR USE
|
US20060142188A1
(en)
|
2003-02-14 |
2006-06-29 |
Memory Pharmaceuticals Corporation |
Monkey alpha-7 nicotinic acetylcholine receptor and methods of use thereof
|
BRPI0407216A
(pt)
|
2003-02-27 |
2006-01-24 |
Neurosearch As |
Derivado de arila diazabicìclica, composição farmacêutica, uso de um derivado de arila diazabicìclica, e, método de tratamento, prevenção ou alìvio de uma doença ou um distúrbio ou uma condição
|
US20050065178A1
(en)
|
2003-09-19 |
2005-03-24 |
Anwer Basha |
Substituted diazabicycloakane derivatives
|
JP2007509935A
(ja)
|
2003-10-31 |
2007-04-19 |
アストラゼネカ アクチボラグ |
アルキンズii
|
CN1871001A
(zh)
|
2003-10-31 |
2006-11-29 |
阿斯利康(瑞典)有限公司 |
炔烃ⅲ
|
CA2549967A1
(en)
|
2003-10-31 |
2005-05-19 |
Astrazeneca Ab |
Alkynes i
|
FR2862647B1
(fr)
|
2003-11-25 |
2008-07-04 |
Aventis Pharma Sa |
Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant
|
US20050245531A1
(en)
|
2003-12-22 |
2005-11-03 |
Abbott Laboratories |
Fused bicycloheterocycle substituted quinuclidine derivatives
|
BRPI0417323A
(pt)
|
2003-12-22 |
2007-03-27 |
Memory Pharm Corp |
indóis, 1h-indazóis, 1,2-benzisoxazóis, e 1,2-benzisotiazóis, composto, composição farmacêutica e usos dos mesmos
|
CN100432075C
(zh)
|
2004-02-04 |
2008-11-12 |
神经研究公司 |
作为烟碱样乙酰胆碱受体配体的二氮杂双环芳基衍生物
|
WO2005074940A1
(en)
|
2004-02-04 |
2005-08-18 |
Neurosearch A/S |
Diazabicyclic aryl derivatives as cholinergic receptor modulators
|
US20070149547A1
(en)
|
2004-02-12 |
2007-06-28 |
Celine Bonnefous |
Bipyridyl amides as modulators of metabotropic glutamate receptor-5
|
SG165199A1
(en)
|
2004-03-25 |
2010-10-28 |
Memory Pharm Corp |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
|
ATE487716T1
(de)
|
2004-04-22 |
2010-11-15 |
Memory Pharm Corp |
Indole, 1h-indazole, 1,2-benzisoxazole, 1,2- benzoisothiazole, deren herstellung und verwendungen
|
AU2005243147A1
(en)
|
2004-05-07 |
2005-11-24 |
Memory Pharmaceuticals Corporation |
1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
|
US7514450B2
(en)
|
2004-05-19 |
2009-04-07 |
Neurosearch A/S |
Azabicyclic aryl derivatives
|
GB0412019D0
(en)
|
2004-05-28 |
2004-06-30 |
Novartis Ag |
Organic compounds
|
PE20060437A1
(es)
|
2004-06-18 |
2006-06-08 |
Novartis Ag |
COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR
|
GB0415746D0
(en)
|
2004-07-14 |
2004-08-18 |
Novartis Ag |
Organic compounds
|
ATE495172T1
(de)
|
2004-10-15 |
2011-01-15 |
Neurosearch As |
Neue azabizyklische arylderivate und medizinische verwendung damit
|
GB0424564D0
(en)
*
|
2004-11-05 |
2004-12-08 |
Novartis Ag |
Organic compounds
|
EP1814887A1
(en)
|
2004-11-15 |
2007-08-08 |
Pfizer Products Incorporated |
Azabenzoxazoles for the treatment of cns disorders
|
WO2006051394A1
(en)
*
|
2004-11-15 |
2006-05-18 |
Pfizer Products Inc. |
Azabenzoxazoles for the treatment of cns disorders
|
AU2005311311A1
(en)
|
2004-11-30 |
2006-06-08 |
Neurosearch A/S |
Novel diazabicyclic aryl derivatives as cholinergy ligands
|
CN1922176A
(zh)
|
2004-12-10 |
2007-02-28 |
艾博特公司 |
稠合的双环杂环取代的奎宁环衍生物
|
WO2006069097A2
(en)
|
2004-12-22 |
2006-06-29 |
Memory Pharmaceuticals Corporation |
Nicotinic alpha-7 receptor ligands and preparation and uses thereof
|
US20060142349A1
(en)
|
2004-12-23 |
2006-06-29 |
Pfizer Inc |
Methods of modulating the activities of alpha-7 nicotinic acetylcholine receptor
|
EP1863819B1
(en)
|
2005-02-16 |
2011-01-12 |
NeuroSearch A/S |
Diazabicyclic aryl derivatives and their use as chinolinergic ligands at the nicotinic acetylcholine receptors
|
NZ560917A
(en)
|
2005-03-31 |
2011-01-28 |
Pfizer Prod Inc |
Cyclopentapyridine and tetrahydroquinoline derivatives
|
JP4995188B2
(ja)
|
2005-04-22 |
2012-08-08 |
シーダーズ−サイナイ・メディカル・センター |
脊髄小脳失調のための組成物および方法
|
FR2884822B1
(fr)
|
2005-04-22 |
2007-06-29 |
Aventis Pharma Sa |
Derives de triazines, leur preparation et leur application en therapeutique
|
GB0508319D0
(en)
|
2005-04-25 |
2005-06-01 |
Novartis Ag |
Organic compounds
|
US8629163B2
(en)
|
2007-10-31 |
2014-01-14 |
University Of Kentucky Research Foundation |
Tetrakis-quaternary ammonium salts and methods for modulating neuronal nicotinic acteylcholine receptors
|
WO2007038367A1
(en)
|
2005-09-23 |
2007-04-05 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
|
GB0521508D0
(en)
|
2005-10-21 |
2005-11-30 |
Novartis Ag |
Organic compounds
|
EP1963332A1
(en)
|
2005-11-09 |
2008-09-03 |
Memory Pharmaceuticals Corporation |
1 h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
|
EP2246352A1
(en)
|
2005-12-06 |
2010-11-03 |
NeuroSearch AS |
Novel diazabicyclic aryl derivatives and their medical use
|
GB0525673D0
(en)
|
2005-12-16 |
2006-01-25 |
Novartis Ag |
Organic compounds
|
GB0525672D0
(en)
|
2005-12-16 |
2006-01-25 |
Novartis Ag |
Organic compounds
|
CA2627630A1
(en)
|
2005-12-20 |
2007-06-28 |
Novartis Ag |
Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
|
US7662965B2
(en)
|
2006-01-26 |
2010-02-16 |
Cornerstone Therapeutics, Inc. |
Anabaseine derivatives, pharmaceutical compositions and method of use thereof
|
WO2007085036A1
(en)
|
2006-01-26 |
2007-08-02 |
Medizinische Universität Wien |
Treatment of friedreich' s ataxia
|
JP2009526776A
(ja)
|
2006-02-14 |
2009-07-23 |
ノイロサーチ アクティーゼルスカブ |
新規なジアザビシクロアルカン誘導体及びその医療上の使用
|
CA2637531A1
(en)
|
2006-02-17 |
2007-08-30 |
Memory Pharmaceuticals Corporation |
Compounds having 5-ht6 receptor affinity
|
JP5730466B2
(ja)
|
2006-02-22 |
2015-06-10 |
アポテックス テクノロジーズ インク.Apotex Technologies Inc. |
鉄の細胞内不良処理からもたらされるフリードライヒ運動失調症の治療及び/又は予防のための方法およびデフェリプロンの使用
|
WO2007110730A2
(en)
|
2006-03-27 |
2007-10-04 |
Pfizer Products Inc. |
Varenicline standards and impurity controls
|
TW200813067A
(en)
|
2006-05-17 |
2008-03-16 |
Astrazeneca Ab |
Nicotinic acetylcholine receptor ligands
|
EP2029607A1
(en)
|
2006-05-23 |
2009-03-04 |
NeuroSearch A/S |
Novel 8,10-diaza-bicycloý4.3.1¨decane derivatives and their medical use
|
DE602007005255D1
(de)
|
2006-05-23 |
2010-04-22 |
Neurosearch As |
Neuartige 1,4-diazabicycloä3.2.2ünonan-derivate und deren medizinische verwendung
|
EP2041134A1
(en)
|
2006-05-30 |
2009-04-01 |
Neurosearch A/S |
Novel 1,4-diaza-bicycloý3.2.2¨nonyl pyrimidinyl derivatives and their medical use
|
DK2032574T3
(da)
|
2006-05-30 |
2010-09-20 |
Neurosearch As |
Hidtil ukendt 1,4-diaza-bicyclo[3.2.2]nonyloxadiazolyl-derivater og medicinsk anvendelse deraf
|
JP5363315B2
(ja)
|
2006-06-06 |
2013-12-11 |
コーナーストーン セラピューティクス インコーポレイテッド |
新規ピペラジン、医薬組成物、およびその使用方法
|
US8178678B2
(en)
|
2006-06-16 |
2012-05-15 |
University Of Kentucky Research Foundation |
Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
|
ATE496894T1
(de)
|
2006-07-14 |
2011-02-15 |
Pfizer Prod Inc |
Tartratsalz von (7s)-7-ä(5-fluor-2-
|
US8314119B2
(en)
|
2006-11-06 |
2012-11-20 |
Abbvie Inc. |
Azaadamantane derivatives and methods of use
|
CL2008000119A1
(es)
|
2007-01-16 |
2008-05-16 |
Wyeth Corp |
Compuestos derivados de pirazol, antagonistas del receptor nicotinico de acetilcolina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como demencia senil, alzheimer y esquizofrenia.
|
US20080200471A1
(en)
|
2007-02-16 |
2008-08-21 |
Memory Pharmaceuticals Corporation |
6' substituted compounds having 5-ht6 receptor affinity
|
US7718677B2
(en)
|
2007-04-02 |
2010-05-18 |
Parkinson's Institute |
Methods and compositions for reduction of side effects of therapeutic treatments
|
EP2162433A2
(en)
|
2007-05-24 |
2010-03-17 |
Memory Pharmaceuticals Corporation |
4' substituted compounds having 5-ht6 receptor affinity
|
SA08290475B1
(ar)
|
2007-08-02 |
2013-06-22 |
Targacept Inc |
(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
|
KR20100053626A
(ko)
|
2007-08-15 |
2010-05-20 |
메모리 파마슈티칼스 코포레이션 |
5-ht6 수용체 친화성을 나타내는 3'-치환된 화합물
|
ATE503754T1
(de)
|
2007-10-01 |
2011-04-15 |
Comentis Inc |
1h-indol-3-carbonsäure-chinuclidin-4- ylmethylesterderivate als liganden für den nikotinischen alpha-7-acetylcholinrezeptor zur behandlung von alzheimer-krankheit
|
CN101815512B
(zh)
|
2007-10-04 |
2013-04-24 |
弗·哈夫曼-拉罗切有限公司 |
环丙基芳基酰胺衍生物和其用途
|
JP5389810B2
(ja)
|
2007-10-04 |
2014-01-15 |
エフ.ホフマン−ラ ロシュ アーゲー |
テトラゾール置換アリールアミド誘導体及びその使用
|
WO2009066107A1
(en)
|
2007-11-21 |
2009-05-28 |
Astrazeneca Ab |
Use of a nicotinic receptor agonist
|
WO2009098576A1
(en)
|
2008-02-05 |
2009-08-13 |
Pfizer Inc. |
Pyridinyl amides for the treatment of cns and metabolic disorders
|
EP2250193B1
(en)
|
2008-02-19 |
2019-09-18 |
Myocept Inc. |
Postsynaptically targeted chemodenervation agents and their methods of use
|
US9463190B2
(en)
|
2008-03-31 |
2016-10-11 |
University Of South Florida |
Methods of treating disease-induced ataxia and non-ataxic imbalance
|
EP2279184B1
(en)
|
2008-04-17 |
2012-08-08 |
Proximagen Limited |
Indole modulators of the alpha-7 nicotinic acetylcholine receptor
|
EP2288345B1
(en)
|
2008-04-18 |
2015-06-10 |
University College Dublin National University Of Ireland, Dublin |
Psycho-pharmaceuticals
|
JP2011520964A
(ja)
|
2008-05-23 |
2011-07-21 |
ユニバーシティ・オブ・サウス・フロリダ |
ニコチン性アセチルコリン受容体活性を有する化合物を用いる末梢感覚神経喪失の治療方法
|
US20100016297A1
(en)
|
2008-06-24 |
2010-01-21 |
Memory Pharmaceuticals Corporation |
Alkyl-substituted 3' compounds having 5-ht6 receptor affinity
|
US20100022581A1
(en)
|
2008-07-02 |
2010-01-28 |
Memory Pharmaceuticals Corporation |
Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinity
|
US20100029629A1
(en)
|
2008-07-25 |
2010-02-04 |
Memory Pharmaceuticals Corporation |
Acyclic compounds having 5-ht6 receptor affinity
|
US20100056531A1
(en)
|
2008-08-22 |
2010-03-04 |
Memory Pharmaceuticals Corporation |
Alkyl-substituted 3' compounds having 5-ht6 receptor affinity
|
US20100056491A1
(en)
|
2008-08-29 |
2010-03-04 |
Memory Pharmaceuticals Corporation |
4'-amino cyclic compounds having 5-ht6 receptor affinity
|
CN102186826B
(zh)
|
2008-10-13 |
2015-06-17 |
弗·哈夫曼-拉罗切有限公司 |
制备双环5-三氟甲氧基-1h-3-吲唑甲酰胺合成中的吲唑中间体的非重氮化方法
|
JP5657556B2
(ja)
|
2008-11-11 |
2015-01-21 |
ターガセプト,インコーポレイテッド |
α7選択的リガンドを用いる治療
|
TW201031664A
(en)
|
2009-01-26 |
2010-09-01 |
Targacept Inc |
Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
|
WO2010147938A2
(en)
|
2009-06-17 |
2010-12-23 |
Targacept, Inc. |
Reversal of l-dopa-induced dyskinesia by neuronal nicotinic receptor ligands
|
CN102573842A
(zh)
|
2009-07-23 |
2012-07-11 |
诺瓦提斯公司 |
氮杂双环烷基衍生物或吡咯烷-2-酮衍生物的用途
|
JO3250B1
(ar)
*
|
2009-09-22 |
2018-09-16 |
Novartis Ag |
إستعمال منشطات مستقبل نيكوتينيك أسيتيل كولين ألفا 7
|